IMMX · Immix Biopharma, Inc.
$13.94
-0.37 (-2.59%)
At close · Aug 28
Going-concern doubt
— flagged Aug 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts of liabilities that may result from uncertainty related to the Company’s ability to continue as a going concern. The continuation of the Company as a going concern is dependent upon its ability to obtain continued financial support from its stockholders, necessary equity financing to continue operations and the attainment of profitable operations.”View the 10-Q filed Aug 7, 2026
Market Cap
$997.26M
Shares
71.54M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-23 | 38,330 | $9.41 | $360,685 |
| 2026-07-22 | 104,229 | $9.57 | $997,472 |
| 2026-07-21 | 8,851 | $8.80 | $77,889 |
| 2026-07-17 | 459 | $10.06 | $4,618 |
| 2026-07-15 | 1,867 | $10.68 | $19,940 |
| 2026-07-02 | 52 | $9.83 | $511 |
| 2026-07-01 | 120 | $10.31 | $1,237 |
| 2026-06-30 | 25,727 | $10.49 | $269,876 |
| 2026-06-25 | 1,573 | $10.04 | $15,793 |
| 2026-06-24 | 173 | $9.91 | $1,714 |
| 2026-06-22 | 212,756 | $8.72 | $1,855,232 |
| 2026-06-18 | 32 | $9.13 | $292 |
| 2026-06-15 | 1,173 | $8.45 | $9,912 |
| 2026-06-12 | 437 | $8.10 | $3,540 |
| 2026-06-11 | 6,449 | $8.18 | $52,753 |
| 2026-06-10 | 8,925 | $8.01 | $71,489 |
| 2026-06-08 | 40,163 | $7.93 | $318,493 |
| 2026-06-01 | 12,044 | $9.00 | $108,396 |
Showing 1–18 of 18 settlements